News

A move to cover expensive weight-loss drugs for Americans on Medicare and Medicaid may be in the works, but any such program ...
The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...
According to the Washington Post, 13 states currently cover the drugs for Medicaid patients, while Medicare prohibits ...
The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of obesity ...
Medicare and Medicaid could expand coverage of GLP-1 drugs, such as Ozempic and Wegovy, and pay for patients’ use of the ...
Blockbuster weight loss drugs like Wegovy and Zepbound have surged in popularity, but high prices have left them out of reach for many obese Americans.
The Center for Medicare and Medicaid Innovation may introduce a five-year pilot model to expand access to weight loss drugs, ...
The Trump administration is planning a five-year test allowing states to cover weight-loss drugs like Ozempic and Wegovy ...
The Trump administration is considering a proposal to allow Medicare and Medicaid to cover expensive weight-loss drugs. GLP-1 ...
The Trump administration is exploring a five-year pilot program to include weight-loss drugs like Wegovy, Ozempic, Zepbound, ...
Medicare is barred under a 2003 law from paying for weight-loss medications like Wegovy. Lawmakers on Thursday reintroduced a bill that would expand Medicare coverage to the drugs.
New weight-loss drugs are out of reach for millions of older Americans because Medicare won’t pay Debra Tyler’s daughter takes her new medication at home in Killingworth, Conn.